Israel Englander Bone Biologics Corp Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.21 - $0.39 $6,142 - $11,407
-29,250 Reduced 62.14%
17,824 $5,000
Q4 2022

Feb 14, 2023
BUY
$0.19 - $32.7 $8,944 - $1.54 Million
47,074 New
47,074 $10,000

About Bone Biologics Corp

BBLG Quotes by TradingView
  • Ticker BBLG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,128,400
  • Market Cap $18.8M
  • Description
  • Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...
More about BBLG
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email